Application of optically stimulated luminescence ‘nanoDot’ dosimeters for dose verification of VMAT treatment planning using an anthropomorphic stereotactic end-to-end verification phantom

Abstract

This paper aims to evaluate the performance of the commercial OSL Landauer InLight System to be applied in dosimetric measurements in a Volumetric Modulated Arc (VMAT) brain tumor planning treatment using a Stereotactic End-To-End Verification Phantom Patient (STEEV™ – CIRS), comparing its results with CaSO4:Dy TLD pellets manufactured and marketed by the Laboratory of Dosimetric Materials/IPEN, PTW PinPoint™ ion chamber and Eclipse 10.0 planning system. The results of commercial InLight™ System using the nanoDot dosimeters showed good reproducibility and stability in both laboratory and clinical measurements. The experimental dose values obtained by all dosimetric techniques varied less than ±1.0% from prescribed by Eclipse 10.0. The intrinsic precision and uncertainty of the OSL reading device were found fair enough, providing good experimental results for VMAT dosimetry.